This company has been marked as potentially delisted and may not be actively trading. DFP Healthcare Acquisitions (DFPH) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock DFPH vs. AGEN, KRRO, CTMX, BHST, CLLS, THTX, RCEL, ENTA, BSGM, and BDTXShould you be buying DFP Healthcare Acquisitions stock or one of its competitors? The main competitors of DFP Healthcare Acquisitions include Agenus (AGEN), Korro Bio (KRRO), CytomX Therapeutics (CTMX), BioHarvest Sciences (BHST), Cellectis (CLLS), Theratechnologies (THTX), Avita Medical (RCEL), Enanta Pharmaceuticals (ENTA), Biosig Technologies (BSGM), and Black Diamond Therapeutics (BDTX). These companies are all part of the "medical" sector. DFP Healthcare Acquisitions vs. Its Competitors Agenus Korro Bio CytomX Therapeutics BioHarvest Sciences Cellectis Theratechnologies Avita Medical Enanta Pharmaceuticals Biosig Technologies Black Diamond Therapeutics Agenus (NASDAQ:AGEN) and DFP Healthcare Acquisitions (NASDAQ:DFPH) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, media sentiment, dividends, earnings and analyst recommendations. Is AGEN or DFPH more profitable? DFP Healthcare Acquisitions has a net margin of 0.00% compared to Agenus' net margin of -167.52%. Agenus' return on equity of 0.00% beat DFP Healthcare Acquisitions' return on equity.Company Net Margins Return on Equity Return on Assets Agenus-167.52% N/A -81.04% DFP Healthcare Acquisitions N/A -107.60%-1.47% Which has better earnings and valuation, AGEN or DFPH? DFP Healthcare Acquisitions has lower revenue, but higher earnings than Agenus. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAgenus$103.46M1.39-$227.21M-$7.15-0.63DFP Healthcare AcquisitionsN/AN/A-$8.34MN/AN/A Does the media refer more to AGEN or DFPH? In the previous week, Agenus had 11 more articles in the media than DFP Healthcare Acquisitions. MarketBeat recorded 11 mentions for Agenus and 0 mentions for DFP Healthcare Acquisitions. Agenus' average media sentiment score of 0.47 beat DFP Healthcare Acquisitions' score of 0.00 indicating that Agenus is being referred to more favorably in the media. Company Overall Sentiment Agenus Neutral DFP Healthcare Acquisitions Neutral Do insiders & institutionals hold more shares of AGEN or DFPH? 61.5% of Agenus shares are owned by institutional investors. 5.5% of Agenus shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has more risk & volatility, AGEN or DFPH? Agenus has a beta of 1.62, meaning that its share price is 62% more volatile than the S&P 500. Comparatively, DFP Healthcare Acquisitions has a beta of 0.03, meaning that its share price is 97% less volatile than the S&P 500. Do analysts prefer AGEN or DFPH? Agenus presently has a consensus price target of $15.50, suggesting a potential upside of 242.69%. Given Agenus' stronger consensus rating and higher possible upside, equities analysts plainly believe Agenus is more favorable than DFP Healthcare Acquisitions.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Agenus 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50DFP Healthcare Acquisitions 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryAgenus beats DFP Healthcare Acquisitions on 10 of the 13 factors compared between the two stocks. Get DFP Healthcare Acquisitions News Delivered to You Automatically Sign up to receive the latest news and ratings for DFPH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DFPH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DFPH vs. The Competition Export to ExcelMetricDFP Healthcare AcquisitionsOffices & Clinics Of Medical Doctors IndustryMedical SectorNASDAQ ExchangeMarket Cap$38.53M$33.61M$5.83B$9.73BDividend YieldN/AN/A3.84%4.09%P/E RatioN/AN/A31.1625.99Price / SalesN/A0.60474.86122.97Price / CashN/A54.0337.1558.38Price / Book-1.540.399.116.38Net Income-$8.34M-$7.06M$3.26B$265.56M DFP Healthcare Acquisitions Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DFPHDFP Healthcare AcquisitionsN/A$1.34flatN/AN/A$38.53MN/A0.00147,000AGENAgenus4.0381 of 5 stars$4.54-5.6%$16.33+259.8%-11.9%$153.27M$103.46M0.00440KRROKorro Bio1.3768 of 5 stars$18.93+18.4%$100.14+429.0%-55.3%$150.15M$2.27M0.0070High Trading VolumeCTMXCytomX Therapeutics4.0795 of 5 stars$1.77-4.8%$5.75+224.9%+59.8%$149.96M$138.10M3.32170High Trading VolumeBHSTBioHarvest SciencesN/A$9.49+4.2%$13.67+44.0%N/A$149.63M$25.19M0.00N/AGap DownCLLSCellectis3.3705 of 5 stars$2.79+4.9%$4.00+43.4%+17.6%$147.85M$49.22M0.00290Short Interest ↓THTXTheratechnologiesN/A$3.23+0.6%N/A+142.5%$147.60M$85.87M0.00140News CoverageShort Interest ↓High Trading VolumeRCELAvita Medical1.4876 of 5 stars$5.76+4.3%$12.40+115.3%-48.5%$146.94M$64.25M0.00130News CoverageENTAEnanta Pharmaceuticals3.666 of 5 stars$7.58+10.5%$21.67+185.8%-32.4%$146.64M$67.64M0.00160BSGMBiosig Technologies1.9427 of 5 stars$4.60-1.5%$10.00+117.4%+1,034.1%$146.30M$40K0.0050Earnings ReportBDTXBlack Diamond Therapeutics3.2618 of 5 stars$2.77+9.1%$12.40+347.7%-58.5%$144.62MN/A11.0490Positive News Related Companies and Tools Related Companies AGEN Competitors KRRO Competitors CTMX Competitors BHST Competitors CLLS Competitors THTX Competitors RCEL Competitors ENTA Competitors BSGM Competitors BDTX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DFPH) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DFP Healthcare Acquisitions Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share DFP Healthcare Acquisitions With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access